Retail Billionaire Wexner Says He Was Duped by Epstein
Les Wexner, founder of a retail empire behind Victoria's Secret, testified before Congress that he was duped by Jeffr...
Which Cash Back Cards Are Best This Year
Learn which cash back cards are best this year and make informed decisions for your spending. Start saving today!
27,108 articles
Ethereum Price Analysis: 4-Hour Triangle Breakout This Week
Ethereum is shaping a decisive move as the 4-hour chart tightens into a triangle. A breakout above the upper line cou...
Missed Nvidia? Missed Tesla? The AI Marketing Bet at $0.85
A fresh, AI-driven marketing venture is selling Reg A+ shares at $0.85 to private investors, promising rapid ROI and ...
Price Prediction: Ripple Deploys Billions to Bridge Banks
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...
Buterin Says Ethereum’s Biggest Bottlenecks Need Fix
Vitalik Buterin unveils a plan to overhaul Ethereum’s execution layer, targeting state tree and VM bottlenecks to unl...
Altcoin ETF Surge: SOL and XRP Pull $23M Inflows Now
Institutional buyers poured $23.25 million into SOL and XRP ETFs on March 4, 2026, signaling a shift toward altcoins ...
Bitcoin Going Die: Latest Death Warnings Roil Markets
A famous Oscar-nominated star on a popular podcast warned that bitcoin going die latest, sparking fresh volatility as...
HMRC Explores Crypto Forensic Tools for Tax Probes Push
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
Nasdaq Adena Friedman: AI Is Growth, Not Death for Software
Nasdaq CEO Adena Friedman frames AI as a growth catalyst for software, not a ruinous force. Her remarks come as softw...
Vertiv CEO: Liquid Cooling Capacity Surges for AI Centers
Vertiv CEO Giordano Albertazzi says liquid cooling capacity is expanding rapidly to support surging AI infrastructure...
Rethinking Diversification: Where Blue-Chip Art Fits In
Investors are increasingly adding blue-chip art to mainstream portfolios to diversify beyond stocks and bonds. Fracti...
Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status